PLCXD3 and metabolic dysfunction-associated steatotic liver disease: These results suggested that these three common signature genes (PLCXD3, CCL19, and PKD2) and nomogram models can serve as effective diagnostic biomarkers for distinguishing advanced AS and NAFLD.